FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170401510> ?p ?o ?g. }

• W2170401510 endingPage "2661" @default.
• W2170401510 startingPage "2653" @default.
• W2170401510 abstract "OBJECTIVE The efficacy of liraglutide, a human glucagon-like peptide-1 (GLP-1) analog, to prevent or delay diabetes in UCD-T2DM rats, a model of polygenic obese type 2 diabetes, was investigated. RESEARCH DESIGN AND METHODS At 2 months of age, male rats were divided into three groups: control, food-restricted, and liraglutide. Animals received liraglutide (0.2 mg/kg s.c.) or vehicle injections twice daily. Restricted rats were food restricted to equalize body weights to liraglutide-treated rats. Half of the animals were followed until diabetes onset, whereas the other half of the animals were killed at 6.5 months of age for tissue collection. RESULTS Before diabetes onset energy intake, body weight, adiposity, and liver triglyceride content were higher in control animals compared with restricted and liraglutide-treated rats. Energy-restricted animals had lower food intake than liraglutide-treated animals to maintain the same body weights, suggesting that liraglutide increases energy expenditure. Liraglutide treatment delayed diabetes onset by 4.1 ± 0.8 months compared with control (P &lt; 0.0001) and by 1.3 ± 0.8 months compared with restricted animals (P &lt; 0.05). Up to 6 months of age, energy restriction and liraglutide treatment lowered fasting plasma glucose and A1C concentrations compared with control animals. In contrast, liraglutide-treated animals exhibited lower fasting plasma insulin, glucagon, and triglycerides compared with both control and restricted animals. Furthermore, energy-restricted and liraglutide-treated animals exhibited more normal islet morphology. CONCLUSIONS Liraglutide treatment delays the development of diabetes in UCD-T2DM rats by reducing energy intake and body weight, and by improving insulin sensitivity, improving lipid profiles, and maintaining islet morphology." @default.
• W2170401510 created "2016-06-24" @default.
• W2170401510 creator A5010282554 @default.
• W2170401510 creator A5034829692 @default.
• W2170401510 creator A5035450241 @default.
• W2170401510 creator A5054084621 @default.
• W2170401510 creator A5056635157 @default.
• W2170401510 creator A5062936288 @default.
• W2170401510 creator A5064830959 @default.
• W2170401510 creator A5073614725 @default.
• W2170401510 creator A5081546127 @default.
• W2170401510 creator A5088627727 @default.
• W2170401510 date "2010-07-09" @default.
• W2170401510 modified "2023-09-30" @default.
• W2170401510 title "Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats" @default.
• W2170401510 cites W1888368658 @default.
• W2170401510 cites W1975756049 @default.
• W2170401510 cites W1986331352 @default.
• W2170401510 cites W1996033370 @default.
• W2170401510 cites W2003604699 @default.
• W2170401510 cites W2008411184 @default.
• W2170401510 cites W2011823591 @default.
• W2170401510 cites W2013851956 @default.
• W2170401510 cites W2021022471 @default.
• W2170401510 cites W2048981028 @default.
• W2170401510 cites W2067314875 @default.
• W2170401510 cites W2070271057 @default.
• W2170401510 cites W2071835038 @default.
• W2170401510 cites W2076805031 @default.
• W2170401510 cites W2080128749 @default.
• W2170401510 cites W2084948079 @default.
• W2170401510 cites W2088987697 @default.
• W2170401510 cites W2090898804 @default.
• W2170401510 cites W2098459806 @default.
• W2170401510 cites W2102752610 @default.
• W2170401510 cites W2108282017 @default.
• W2170401510 cites W2108672863 @default.
• W2170401510 cites W2109327370 @default.
• W2170401510 cites W2109432892 @default.
• W2170401510 cites W2113544353 @default.
• W2170401510 cites W2114416343 @default.
• W2170401510 cites W2119804129 @default.
• W2170401510 cites W2128181185 @default.
• W2170401510 cites W2132956041 @default.
• W2170401510 cites W2133545915 @default.
• W2170401510 cites W2137352234 @default.
• W2170401510 cites W2138290933 @default.
• W2170401510 cites W2145329719 @default.
• W2170401510 cites W2146156707 @default.
• W2170401510 cites W2156689802 @default.
• W2170401510 cites W2158342810 @default.
• W2170401510 cites W2160001758 @default.
• W2170401510 cites W2168526937 @default.
• W2170401510 cites W2170606300 @default.
• W2170401510 doi "https://doi.org/10.2337/db09-1564" @default.
• W2170401510 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3279561" @default.
• W2170401510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20622169" @default.
• W2170401510 hasPublicationYear "2010" @default.
• W2170401510 type Work @default.
• W2170401510 sameAs 2170401510 @default.
• W2170401510 citedByCount "64" @default.
• W2170401510 countsByYear W21704015102012 @default.
• W2170401510 countsByYear W21704015102013 @default.
• W2170401510 countsByYear W21704015102014 @default.
• W2170401510 countsByYear W21704015102015 @default.
• W2170401510 countsByYear W21704015102016 @default.
• W2170401510 countsByYear W21704015102017 @default.
• W2170401510 countsByYear W21704015102018 @default.
• W2170401510 countsByYear W21704015102019 @default.
• W2170401510 countsByYear W21704015102020 @default.
• W2170401510 countsByYear W21704015102021 @default.
• W2170401510 countsByYear W21704015102022 @default.
• W2170401510 countsByYear W21704015102023 @default.
• W2170401510 crossrefType "journal-article" @default.
• W2170401510 hasAuthorship W2170401510A5010282554 @default.
• W2170401510 hasAuthorship W2170401510A5034829692 @default.
• W2170401510 hasAuthorship W2170401510A5035450241 @default.
• W2170401510 hasAuthorship W2170401510A5054084621 @default.
• W2170401510 hasAuthorship W2170401510A5056635157 @default.
• W2170401510 hasAuthorship W2170401510A5062936288 @default.
• W2170401510 hasAuthorship W2170401510A5064830959 @default.
• W2170401510 hasAuthorship W2170401510A5073614725 @default.
• W2170401510 hasAuthorship W2170401510A5081546127 @default.
• W2170401510 hasAuthorship W2170401510A5088627727 @default.
• W2170401510 hasBestOaLocation W21704015101 @default.
• W2170401510 hasConcept C126322002 @default.
• W2170401510 hasConcept C134018914 @default.
• W2170401510 hasConcept C2776398474 @default.
• W2170401510 hasConcept C2777180221 @default.
• W2170401510 hasConcept C2778563252 @default.
• W2170401510 hasConcept C2779306644 @default.
• W2170401510 hasConcept C2781308992 @default.
• W2170401510 hasConcept C555293320 @default.
• W2170401510 hasConcept C71924100 @default.
• W2170401510 hasConceptScore W2170401510C126322002 @default.
• W2170401510 hasConceptScore W2170401510C134018914 @default.
• W2170401510 hasConceptScore W2170401510C2776398474 @default.
• W2170401510 hasConceptScore W2170401510C2777180221 @default.

• next